Dr Reddy's receives two USFDA observations for New York API...

Dr Reddy's receives two USFDA observations for New York API facility

Posted

129

Dr. Reddy's Laboratories faced USFDA scrutiny at its New York API facility, receiving a Form 483 with two observations after a GMP inspection concluded on May 16, 2025. The company will address these concerns within the given timeframe.

Read Full Article

Please log in to like, share and comment!

National

Maharashtra: Uddhav Sena's men trace & assault autowala over Marathi

By 0 11

International

‘Most iconic moment’: One year of Trump’s assassination attempt at Butler; ‘cascade of preventable failures’, says Senate committee

US President Donald Trump attended a soccer match with his family. The match coincided with the...

By 0 11

National

Samosa, jalebi join cigarettes on health alert list

By 0 27

National

Jammu and Kashmir Lt Governor Manoj Sinha hands over job letters to kin of terror victims

By 0 27

International

UAE and GCC residents can now invest directly in Saudi Arabia’s main stock market, Tadawul

Saudi Arabia has opened its main stock market, Tadawul, to direct investment by GCC residents for...

By 0 36